4.7 Article

Tissue-specific pathways extrude activated ILC2s to disseminate type 2 immunity

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 217, 期 4, 页码 -

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20191172

关键词

-

资金

  1. National Institutes of Health [R01AI026918, R01HL128903, K08AR075880, F30AI122702, T32GM007618]
  2. Howard Hughes Medical Institute
  3. Sandler Asthma Basic Research Center at UCSF
  4. Swiss National Science Foundation [P2EZP3_162266, P300PA_171591, P4P4PM_180832]
  5. Dermatology Foundation
  6. A.P. Giannini Foundation
  7. Robert Wood Johnson Foundation [74257]
  8. Swiss National Science Foundation (SNF) [P2EZP3_162266, P300PA_171591, P4P4PM_180832] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

Group 2 innate lymphoid cells (ILC2s) are tissue-resident cells prominent at barrier sites. Although precursors are found in blood, mature ILC2s can enter the circulation after small intestinal perturbation by migratory helminths and move to distant tissues to influence the local reparative response. Using fate-mapping and methods to bypass the lung or intestinal phases of Nippostrongylus brasiliensis infection, we show that blood ILC2s comprise heterogeneous populations derived from distinct tissues that are dependent on alarmins matched to the receptor profile of the specific tissue ILC2s. Activation of local ILC2s by tissue-specific alarmins induced their proliferation, lymph node migration, and blood dissemination, thus systemically distributing type 2 cytokines. These studies uncover a possible mechanism by which local innate responses transition to systemic type 2 responses by extrusion of activated sentinel ILC2s from tissue into the circulation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据